FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2017480010> ?p ?o ?g. }

• W2017480010 endingPage "798" @default.
• W2017480010 startingPage "790" @default.
• W2017480010 abstract "Abstract Background Psoriasis is known to have a significant negative impact on a patient's health‐related quality of life, including social, recreational and work activities. Objective To evaluate the effects of briakinumab on quality of life and work productivity measures in patients with moderate to severe psoriasis. Methods Patients received either briakinumab ( n = 981) or placebo ( n = 484) during the 12‐week induction phase of trial M06‐890. At week 12, patients with a Physician's Global Assessment score of ‘Clear’ or ‘Minimal’ entered the 40‐week maintenance phase and were to receive briakinumab every 4 weeks, briakinumab every 12 weeks, or placebo. At weeks 12 and 52, treatment groups were compared using mean change from baseline in health‐related quality of life and Work Productivity and Activity Impairment Questionnaire scores and the percentage of patients with minimum clinically important differences. Results At week 12, more than half of the briakinumab‐treated patients achieved improvements meeting or exceeding minimum clinically important differences for Dermatology Life Quality Index (75.9%), and psoriasis‐ (64.8%), and psoriatic arthritis‐related (54.1%) pain scores; 48.4% achieved improvements for activity impairment. Although improvements in quality of life and work productivity measures were maintained at week 52 for both briakinumab regimens, responder rates were consistently greater in the every‐4‐week group than in the every‐12‐week group. Conclusion Briakinumab treatment resulted in clinically significant improvements in quality of life and work productivity in adults with moderate to severe psoriasis. Maintenance therapy was associated with a more pronounced benefit for the every‐4‐week briakinumab regimen." @default.
• W2017480010 created "2016-06-24" @default.
• W2017480010 creator A5002050606 @default.
• W2017480010 creator A5008286260 @default.
• W2017480010 creator A5021207633 @default.
• W2017480010 creator A5035579371 @default.
• W2017480010 creator A5039428639 @default.
• W2017480010 creator A5040838985 @default.
• W2017480010 creator A5042680411 @default.
• W2017480010 creator A5056346259 @default.
• W2017480010 creator A5071662729 @default.
• W2017480010 date "2013-05-17" @default.
• W2017480010 modified "2023-10-18" @default.
• W2017480010 title "Effects of briakinumab treatment for moderate to severe psoriasis on health‐related quality of life and work productivity and activity impairment: results from a randomized phase III study" @default.
• W2017480010 cites W1600222105 @default.
• W2017480010 cites W1751814457 @default.
• W2017480010 cites W1877047792 @default.
• W2017480010 cites W1909750378 @default.
• W2017480010 cites W1970076597 @default.
• W2017480010 cites W1972882465 @default.
• W2017480010 cites W1978428707 @default.
• W2017480010 cites W1978824248 @default.
• W2017480010 cites W1991068078 @default.
• W2017480010 cites W1993273784 @default.
• W2017480010 cites W2005428052 @default.
• W2017480010 cites W2012581664 @default.
• W2017480010 cites W2019320114 @default.
• W2017480010 cites W2023733075 @default.
• W2017480010 cites W2024814916 @default.
• W2017480010 cites W2043469120 @default.
• W2017480010 cites W2045660254 @default.
• W2017480010 cites W2048586949 @default.
• W2017480010 cites W2056361036 @default.
• W2017480010 cites W2062964437 @default.
• W2017480010 cites W2080165152 @default.
• W2017480010 cites W2086325363 @default.
• W2017480010 cites W2086861262 @default.
• W2017480010 cites W2087905758 @default.
• W2017480010 cites W2091442391 @default.
• W2017480010 cites W2096991001 @default.
• W2017480010 cites W2097935815 @default.
• W2017480010 cites W2098835966 @default.
• W2017480010 cites W2105318078 @default.
• W2017480010 cites W2112031699 @default.
• W2017480010 cites W2115975147 @default.
• W2017480010 cites W2116956799 @default.
• W2017480010 cites W2122897116 @default.
• W2017480010 cites W2123773361 @default.
• W2017480010 cites W2134206785 @default.
• W2017480010 cites W2141045409 @default.
• W2017480010 cites W2151566115 @default.
• W2017480010 cites W2164011121 @default.
• W2017480010 cites W2164533070 @default.
• W2017480010 cites W2170270641 @default.
• W2017480010 cites W2742484040 @default.
• W2017480010 doi "https://doi.org/10.1111/jdv.12177" @default.
• W2017480010 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23679896" @default.
• W2017480010 hasPublicationYear "2013" @default.
• W2017480010 type Work @default.
• W2017480010 sameAs 2017480010 @default.
• W2017480010 citedByCount "23" @default.
• W2017480010 countsByYear W20174800102013 @default.
• W2017480010 countsByYear W20174800102014 @default.
• W2017480010 countsByYear W20174800102015 @default.
• W2017480010 countsByYear W20174800102016 @default.
• W2017480010 countsByYear W20174800102017 @default.
• W2017480010 countsByYear W20174800102018 @default.
• W2017480010 countsByYear W20174800102019 @default.
• W2017480010 countsByYear W20174800102020 @default.
• W2017480010 countsByYear W20174800102021 @default.
• W2017480010 countsByYear W20174800102023 @default.
• W2017480010 crossrefType "journal-article" @default.
• W2017480010 hasAuthorship W2017480010A5002050606 @default.
• W2017480010 hasAuthorship W2017480010A5008286260 @default.
• W2017480010 hasAuthorship W2017480010A5021207633 @default.
• W2017480010 hasAuthorship W2017480010A5035579371 @default.
• W2017480010 hasAuthorship W2017480010A5039428639 @default.
• W2017480010 hasAuthorship W2017480010A5040838985 @default.
• W2017480010 hasAuthorship W2017480010A5042680411 @default.
• W2017480010 hasAuthorship W2017480010A5056346259 @default.
• W2017480010 hasAuthorship W2017480010A5071662729 @default.
• W2017480010 hasConcept C126322002 @default.
• W2017480010 hasConcept C139719470 @default.
• W2017480010 hasConcept C142724271 @default.
• W2017480010 hasConcept C159110408 @default.
• W2017480010 hasConcept C16005928 @default.
• W2017480010 hasConcept C162324750 @default.
• W2017480010 hasConcept C168563851 @default.
• W2017480010 hasConcept C1862650 @default.
• W2017480010 hasConcept C204787440 @default.
• W2017480010 hasConcept C204983608 @default.
• W2017480010 hasConcept C27081682 @default.
• W2017480010 hasConcept C2776173921 @default.
• W2017480010 hasConcept C2776260265 @default.
• W2017480010 hasConcept C2779951463 @default.
• W2017480010 hasConcept C2780564577 @default.
• W2017480010 hasConcept C2992962319 @default.
• W2017480010 hasConcept C30036603 @default.

• next